Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon E Ward

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Cancer Science & Therapy|September 19, 2014
TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to TopotecanCornelia Meisenberg, Simon E Ward, Peter Schmid, et al.
Royal Society Open Science|August 16, 2018
Metal-free selective mono-halodecarboxylation of heteroarenes under mild conditionsScott H Henderson, Ryan A West, Simon E Ward, et al.
Organic & Biomolecular Chemistry|June 7, 2007
Synthetic studies towards garsubellin A: synthesis of model systems and potential mimics by regioselective lithiation of bicyclo[3.3.1]nonane-2,4,9-trione derivatives from catechinic acidNadia M Ahmad, Vincent Rodeschini, Nigel S Simpkins, et al.
Biomolecules|August 26, 2023
Central Nervous System Targeted Protein DegradersBedwyr Ab Ion Thomas, H Lois Lewis, D Heulyn Jones, et al.
The Journal of Organic Chemistry|May 29, 2007
Synthesis of polyprenylated acylphloroglucinols using bridgehead lithiation: the total synthesis of racemic clusianone and a formal synthesis of racemic garsubellin ANadia M Ahmad, Vincent Rodeschini, Nigel S Simpkins, et al.
Oncotarget|June 2, 2020
Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2Leanne Milton-Harris, Mark Jeeves, Sarah A Walker, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
N-substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulatorsKevin M Thewlis, Laura Aldegheri, Mark H Harries, et al.
ACS Infectious Diseases|January 23, 2018
Toward More Drug Like Inhibitors of Trypanosome Alternative OxidaseRyan A West, Thomas Cunningham, Lewis E Pennicott, et al.
Nature Reviews. Cancer|February 25, 2015
Therapeutic opportunities within the DNA damage responseLaurence H Pearl, Amanda C Schierz, Simon E Ward, et al.
Pharmacology & Therapeutics|January 24, 2018
CCRK is a novel signalling hub exploitable in cancer immunotherapyMyth T Mok, Jingying Zhou, Wenshu Tang, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Cancer Science & Therapy|September 19, 2014
TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to TopotecanCornelia Meisenberg, Simon E Ward, Peter Schmid, et al.
Royal Society Open Science|August 16, 2018
Metal-free selective mono-halodecarboxylation of heteroarenes under mild conditionsScott H Henderson, Ryan A West, Simon E Ward, et al.
Organic & Biomolecular Chemistry|June 7, 2007
Synthetic studies towards garsubellin A: synthesis of model systems and potential mimics by regioselective lithiation of bicyclo[3.3.1]nonane-2,4,9-trione derivatives from catechinic acidNadia M Ahmad, Vincent Rodeschini, Nigel S Simpkins, et al.
Biomolecules|August 26, 2023
Central Nervous System Targeted Protein DegradersBedwyr Ab Ion Thomas, H Lois Lewis, D Heulyn Jones, et al.
The Journal of Organic Chemistry|May 29, 2007
Synthesis of polyprenylated acylphloroglucinols using bridgehead lithiation: the total synthesis of racemic clusianone and a formal synthesis of racemic garsubellin ANadia M Ahmad, Vincent Rodeschini, Nigel S Simpkins, et al.
Oncotarget|June 2, 2020
Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2Leanne Milton-Harris, Mark Jeeves, Sarah A Walker, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
N-substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulatorsKevin M Thewlis, Laura Aldegheri, Mark H Harries, et al.
ACS Infectious Diseases|January 23, 2018
Toward More Drug Like Inhibitors of Trypanosome Alternative OxidaseRyan A West, Thomas Cunningham, Lewis E Pennicott, et al.
Nature Reviews. Cancer|February 25, 2015
Therapeutic opportunities within the DNA damage responseLaurence H Pearl, Amanda C Schierz, Simon E Ward, et al.
Pharmacology & Therapeutics|January 24, 2018
CCRK is a novel signalling hub exploitable in cancer immunotherapyMyth T Mok, Jingying Zhou, Wenshu Tang, et al.
Pageof 6